Real incidence of diabetes mellitus in a coronary disease population

American Journal of Cardiology

Volumn 111, Issue 3, 2013, Pages 333-338

  De La Hera, Jesús M ^a   García Ruiz, Jose M ^a   Martínez Camblor, Pablo ^b   Martín, María ^a   Tellería, Ana L ^a,c   Corros, Cecilia ^a   Torres, Francisco ^a   Fernández Cimadevilla, Oliva C ^a   Alvarez Pichel, Irene ^a   Capín, Esmeralda ^a   Avanzas, Pablo ^a   Delgado, Elías ^a  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^b Oficina de Investigación Biosanitaria OIB de Asturias and Universidad Autonoma de Chile   (Spain)

^c Hospital Universitario Dr Rafael Calles Sierra   (Venezuela)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLYCOSYLATED HEMOGLOBIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FEMALE; FOLLOW UP; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INCIDENCE; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; RISK ASSESSMENT;

AGED; BLOOD GLUCOSE; CORONARY DISEASE; DIABETES MELLITUS; EUROPE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84872360563     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2012.10.008     Document Type: Article

References (29)

1. S.L. Hardoon, R.W. Morris, M.C. Thomas, S.G. Wannamethee, L.T. Lennon, and P.H. Whincup Is the recent rise in type 2 diabetes incidence from 1984 to 2007 explained by the trend in increasing BMI? Evidence from a prospective study of British men Diabetes Care 33 2010 1494 1496
2. S. Wild, G. Roglic, A. Green, R. Sicree, and H. King Global prevalence of diabetes: estimates for the year 2000 and projections for 2030 Diabetes Care 27 2004 1047 1053
3. F. Soriguer, A. Goday, A. Bosch-Comas, E. Bordiú, A. Calle-Pascual, R. Carmena, R. Casamitjana, L. Castaño, C. Castell, M. Catalá, E. Delgado, J. Franch, S. Gaztambide, J. Girbés, R. Gomis, G. Gutiérrez, A. López-Alba, M.T. Martínez-Larrad, E. Menéndez, I. Mora-Peces, E. Ortega, G. Pascual-Manich, G. Rojo-Martínez, M. Serrano-Rios, S. Valdés, J.A. Vázquez, and J. Vendrell Prevalence of diabetes mellitus and impaired glucose regulation in Spain: the Di@bet.es Study Diabetologia 55 2012 88 93
4. D.J. Magliano, E.L.M. Barr, P.Z. Zimmet, A.J. Cameron, D.W. Dunstan, S. Colagiuri, D. Jolley, N. Owen, P. Phillips, R.J. Tapp, T.A. Welborn, and J.E. Shaw Glucose indices, health behaviors, and incidence of diabetes in Australia: the Australian Diabetes, Obesity and Lifestyle Study Diabetes Care 31 2008 267 272
5. S. Valdés, P. Botas, E. Delgado, F. Alvarez, and F.D. Cadórniga Population-based incidence of type 2 diabetes in northern Spain: the Asturias Study Diabetes Care 30 2007 2258 2263
6. M. Bartnik, L. Rydén, R. Ferrari, K. Malmberg, K. Pyörälä, M. Simoons, E. Standl, J. Soler-Soler, and J. Ohrvik Euro Heart Survey on Diabetes and the Heart. The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe Eur Heart J 25 2004 1880 1890
7. J.M. de la Hera, E. Delgado, E. Hernández, J.M. García-Ruiz, J.M. Vegas, P. Avanzas, I. Lozano, R. Barriales-Villa, S. Hevia, J.S. Martín, F. Alvarez, and C. Morís Prevalence and outcome of newly detected diabetes in patients who undergo percutaneous coronary intervention Eur Heart J 30 2009 2614 2621
8. D.-Y. Hu, C.-Y. Pan, and J.-M. Yu The relationship between coronary artery disease and abnormal glucose regulation in China: the China Heart survey Eur Heart J 27 2006 2573 2579
9. A. Norhammar, A. Tenerz, G. Nilsson, A. Hamsten, S. Efendíc, L. Rydén, and K. Malmberg Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study Lancet 359 2002 2140 2144
10. C. Meisinger, J. Beck, M. Heier, A. Hörmann, B. Kuch, G. Sietas, and W. Koenig Myocardial infarction and incidence of type 2 diabetes mellitus: is admission blood glucose an independent predictor for future type 2 diabetes mellitus? Am Heart J 159 2010 258 263
11. D. Mozaffarian, R. Marfisi, G. Levantesi, M.G. Silletta, L. Tavazzi, G. Tognoni, F. Valagussa, and R. Marchioli Incidence of new-onset diabetes and impaired fasting glucose in patients with recent myocardial infarction and the effect of clinical and lifestyle risk factors Lancet 370 2007 667 675
12. P. Pajunen, H. Koukkunen, M. Ketonen, T. Jerkkola, P. Immonen-Räihä, P. Kärjä-Koskenkari, M. Mähönen, M. Niemelä, K. Kuulasmaa, P. Palomäki, J. Mustonen, A. Lehtonen, M. Arstila, T. Vuorenmaa, S. Lehto, H. Miettinen, A. Juolevi, J. Torppa, J. Tuomilehto, Y.A. Kesäniemi, K. Pyörälä, and V. Salomaa Five-year risk of developing clinical diabetes after first myocardial infarction: the FINAMI study Diabet Med 22 2005 1334 1337
13. L. Rydén, E. Standl, M. Bartnik, G. Van den Berghe, J. Betteridge, M.-J. de Boer, F. Cosentino, B. Jönsson, M. Laakso, K. Malmberg, S. Priori, J. Ostergren, J. Tuomilehto, I. Thrainsdottir, I. Vanhorebeek, M. Stramba-Badiale, P. Lindgren, Q. Qiao, S.G. Priori, J.-J. Blanc, A. Budaj, J. Camm, V. Dean, J. Deckers, K. Dickstein, J. Lekakis, K. McGregor, M. Metra, J. Morais, A. Osterspey, J. Tamargo, J.L. Zamorano, J.W. Deckers, M. Bertrand, B. Charbonnel, E. Erdmann, E. Ferrannini, A. Flyvbjerg, H. Gohlke, J.R.G. Juanatey, I. Graham, P.F. Monteiro, K. Parhofer, K. Pyörälä, I. Raz, G. Schernthaner, M. Volpe, and D. Wood Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary: the Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD) Eur Heart J 28 2007 88 136
14. J. Drozda, J.V. Messer, J. Spertus, B. Abramowitz, K. Alexander, C.T. Beam, R.O. Bonow, J.S. Burkiewicz, M. Crouch, D.C. Goff, R. Hellman, T. James, M.L. King, E.A. Machado, E. Ortiz, M. O'Toole, S.D. Persell, J.M. Pines, F.J. Rybicki, L.B. Sadwin, J.D. Sikkema, P.K. Smith, P.J. Torcson, and J.B. Wong ACCF/AHA/AMA-PCPI 2011 performance measures for adults with coronary artery disease and hypertension: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures and the American Medical Association JACC 58 2011 316 336
15. Diagnosis and classification of diabetes mellitus Diabetes Care 33 Suppl 1 2010 S62 S69
16. K.G. Alberti, and P.Z. Zimmet Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation Diabet Med 15 1998 539 553
17. D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, and R.C. Turner Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 1985 412 419
18. W. Hoelzel, C. Weykamp, J.-O. Jeppsson, K. Miedema, J.R. Barr, I. Goodall, T. Hoshino, W.G. John, U. Kobold, R. Little, A. Mosca, P. Mauri, R. Paroni, F. Susanto, I. Takei, L. Thienpont, M. Umemoto, and H.-M. Wiedmeyer IFCC reference system for measurement of hemoglobin A1c in human blood and the national standardization schemes in the United States, Japan, and Sweden: a method-comparison study Clin Chem 50 2004 166 174
19. J.M. de la Hera, J.M. Vegas, E. Hernández, I. Lozano, J.M. García-Ruiz, O.C. Fernández-Cimadevilla, A. Carro, P. Avanzas, F. Torres, J. Bayón, T. Menéndez, M. Jiménez-Navarro, and E. Delgado Performance of glycated hemoglobin and a risk model for detection of unknown diabetes in coronary patients Rev Esp Cardiol 64 2011 759 765
20. S.R.K. Seshasai, S. Kaptoge, A. Thompson, E. Di Angelantonio, P. Gao, N. Sarwar, P.H. Whincup, K.J. Mukamal, R.F. Gillum, I. Holme, I. Njølstad, A. Fletcher, P. Nilsson, S. Lewington, R. Collins, V. Gudnason, S.G. Thompson, N. Sattar, E. Selvin, F.B. Hu, and J. Danesh Diabetes mellitus, fasting glucose, and risk of cause-specific death N Engl J Med 364 2011 829 841
21. E. Selvin, M.W. Steffes, H. Zhu, K. Matsushita, L. Wagenknecht, J. Pankow, J. Coresh, and F.L. Brancati Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults N Engl J Med 362 2010 800 811
22. X. Zhang, E.W. Gregg, D.F. Williamson, L.E. Barker, W. Thomas, K.M. Bullard, G. Imperatore, D.E. Williams, and A.L. Albright A1c level and future risk of diabetes: a systematic review Diabetes Care 33 2010 1665 1673
23. E.S. Ford, C. Li, and N. Sattar Metabolic syndrome and incident diabetes: current state of the evidence Diabetes Care 31 2008 1898 1904
24. D. Noble, R. Mathur, T. Dent, C. Meads, and T. Greenhalgh Risk models and scores for type 2 diabetes: systematic review BMJ 343 2011 d7163
25. J. Lindström, P. Absetz, K. Hemiö, P. Peltomäki, and M. Peltonen Reducing the risk of type 2 diabetes with nutrition and physical activity - efficacy and implementation of lifestyle interventions in Finland Public Health Nutrition 13 2010 993 999
26. The 10-year cost-effectiveness of lifestyle intervention or metformin for diabetes prevention: an intent-to-treat analysis of the DPP/DPPOS Diabetes Care 35 2012 723 730
27. Long-term safety, tolerability, and weight loss associated with metformin in the diabetes prevention program outcomes study Diabetes Care 35 2012 731 737
28. J.J. McMurray, R.R. Holman, S.M. Haffner, M.A. Bethel, B. Holzhauer, T.A. Hua, Y. Belenkov, M. Boolell, J.B. Buse, B.M. Buckley, A.R. Chacra, F.-T. Chiang, B. Charbonnel, C.-C. Chow, M.J. Davies, P. Deedwania, P. Diem, D. Einhorn, V. Fonseca, G.R. Fulcher, Z. Gaciong, S. Gaztambide, T. Giles, E. Horton, H. Ilkova, T. Jenssen, S.E. Kahn, H. Krum, M. Laakso, L.A. Leiter, N.S. Levitt, V. Mareev, F. Martinez, C. Masson, T. Mazzone, E. Meaney, R. Nesto, C. Pan, R. Prager, S.A. Raptis, G.E.H.M. Rutten, H. Sandstroem, F. Schaper, A. Scheen, O. Schmitz, I. Sinay, V. Soska, S. Stender, G. Tamás, G. Tognoni, J. Tuomilehto, A.S. Villamil, J. Vozár, and R.M. Califf Effect of valsartan on the incidence of diabetes and cardiovascular events N Engl J Med 362 2010 1477 1490
29. J.I. Barzilay, B.R. Davis, J.A. Cutler, S.L. Pressel, P.K. Whelton, J. Basile, K.L. Margolis, S.T. Ong, L.S. Sadler, and J. Summerson Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Arch Intern Med 166 2006 2191 2201